Blog

Newsletter – April 2024 – Biotech Fund

Thursday, 23rd May, 2024

The equity market stumbled in April with the S&P 500 decreasing by 4.1%, breaking its streak of five consecutive positive months. Read more.

Read more

Newsletter – April 2024 – Opportunities Fund

Monday, 20th May, 2024

Are they, aren’t they, they are, they aren’t – Interest Rates. Read more.

Read more

Newsletter – March 2024 – Biotech Fund

Monday, 29th April, 2024

The Merchant Biotech Fund retreated a little this month finishing the month at $1.3940. Read more.

Read more

Newsletter – March 2024 – Opportunities Fund

Monday, 22nd April, 2024

The MOF continued to recover through the month of March. Read more.

Read more

Newsletter – February 2024 – Opportunities Fund

Tuesday, 26th March, 2024

The MOF rebounded slightly in February. Read more.

Read more

Newsletter – February 2024 – Biotech Fund

Tuesday, 19th March, 2024

The month of February was a strong month for the Merchant Biotech Fund (Fund or MBF) finishing up 16.71%. Read more.  

Read more

Newsletter – January 2024 – Opportunities Fund

Monday, 26th February, 2024

We are starting to see green shoots in our sector of the market of late. Read more.

Read more

Newsletter – January 2024 – Biotech Fund

Monday, 26th February, 2024

The Merchant Biotech Fund (MBF or Fund) started the 2024 calendar year well, finishing up 11.12% for the month of January. Read more.

Read more

Newsletter – December 2023 – Biotech Fund

Tuesday, 23rd January, 2024

Closing out the year the Merchant Biotech Fund finished up strongly. Read more.

Read more

Newsletter – December 2023 – Opportunities Fund

Tuesday, 23rd January, 2024

Pleasingly the Merchant Opportunities Fund rebounded somewhat during the month of December. Read more.

Read more

Newsletter – November 2023 – Biotech Fund

Thursday, 21st December, 2023

The Merchant Biotech Fund (MBF or Fund) had a strong month in November, finishing at $1.0058. Read more.

Read more

Newsletter – November 2023 – Opportunities Fund

Monday, 18th December, 2023

The bright spot at Merchant has been the performance of the Merchant Biotech Fund. Read more.

Read more

Newsletter – September 2023 – Biotech Fund

Monday, 23rd October, 2023

The general market softened into September and the biotech sector held its ground. Read more.

Read more

Newsletter – September 2023 – Opportunities Fund

Monday, 23rd October, 2023

Greetings from Munich. I am here at the moment assisting HAPA (EuroCann). Read more.

Read more

Newsletter – July 2023 – Biotech Fund

Thursday, 31st August, 2023

At the end of July, it appeared the Australian inflation rate was softening with monthly CPI hitting a 16-month low. Read more.

Read more

Newsletter – July 2023 – Opportunities Fund

Wednesday, 30th August, 2023

A quiet month in the markets post June 30th selling in Small-Cap land. Read more.

Read more

Newsletter – June 2023 – Opportunities Fund

Wednesday, 26th July, 2023

The Merchant Opportunities Fund softened in the month of June. Read more.

Read more

Newsletter – June 2023 – Biotech Fund

Wednesday, 26th July, 2023

The Merchant Biotech Fund finished up 43.25% for the financial year. Read more.

Read more

Newsletter – April 2023 – Biotech Fund

Tuesday, 23rd May, 2023

The Merchant Biotech Fund (“MBF” or “the Fund”) is up 59% for the financial year vs the ASX Healthcare 300 Index (XHK) up 6.09% over the same period. Read more.

Read more

Newsletter – April 2023 – Opportunities Fund

Tuesday, 23rd May, 2023

The overall market was relatively stagnant during the month of April. Read more.

Read more

Newsletter – March 2023 – Biotech Fund

Thursday, 20th April, 2023

The Merchant Biotech Fund closed up 5.5% for the month. Read more.

Read more

Newsletter – March 2023 – Opportunities Fund

Wednesday, 19th April, 2023

March was a tale of two halves – first half being terrible and second half being less terrible… Read more.

Read more

Newsletter – February 2023 – Biotech Fund

Tuesday, 21st March, 2023

Global equities declined in February after a strong January. Merchant Biotech Fund (MBF or Fund) retreated a little to finish the month $0.7691.Read more.

Read more

Newsletter – February 2023 – Opportunities Fund

Tuesday, 21st March, 2023

The month of February was a tale of two halves – first half of the month being relatively good and second half being relatively bad as the index wobbled across the board as a result of continued increases in global interest rates. Read more.

Read more

Newsletter – January 2023 – Biotech Fund

Tuesday, 21st February, 2023

A solid January could be a good sign for the market and potentially foreshadow a continued uptick in the months that follow. Read more.

Read more

Newsletter – January 2023 – Opportunities Fund

Monday, 20th February, 2023

Another relatively benign month for the Merchant Opportunities Fund. Read more.

Read more

Newsletter – December 2022 – Opportunities Fund

Thursday, 19th January, 2023

The Merchant Opportunities Fund (MOF) is currently up 19.60% net of fees since 30 June 2022. Read more.

Read more

Newsletter – December 2022 – Biotech Fund

Thursday, 19th January, 2023

The Merchant Biotech Fund (MBF) finished December up 29.34% for the Financial Year. Read more.

Read more

Newsletter – November 2022 – Biotech Fund

Wednesday, 14th December, 2022

November started on a sombre note amid the Fed’s rate hike and better-than-expected job numbers. Read more.

Read more

Newsletter – November 2022 – Opportunities Fund

Tuesday, 13th December, 2022

The ASX continued to tread water in November and settled into the Christmas trading period with a marked drop in liquidity despite an overall bullish trend. Read more.

Read more

Newsletter – October 2022 – Biotech Fund

Tuesday, 29th November, 2022

Global equity markets rounded the month out higher after a brutal September slump. In the US the Dow ended October with a gain of +13.96%, its best monthly advance since January 1976 and its 10th best month of the last century. Read more.

Read more

Newsletter – October 2022 – Opportunities Fund

Monday, 28th November, 2022

Apologies for the lateness of this newsletter, I’ve just returned from Frankfurt where we’ve been visiting HAPA Pharm, our German Medical Cannabis holding as it readies to list in the new year. Read more.

Read more

Newsletter – September 2022 – Biotech Fund

Tuesday, 18th October, 2022

This month the bear market intensified, with the S&P 500 joining the Dow Jones in undercutting their June lows and the Nasdaq composite sitting just above that level. Read more.

Read more

Newsletter – September 2022 – Opportunities Fund

Tuesday, 18th October, 2022

The Merchant Opportunities Fund (MOF) had a relatively benign month given the global market swings during September. Read more.

Read more

Newsletter – August 2022 – Biotech Fund

Tuesday, 20th September, 2022

The question we wanted answered in July was “can the rally last?”  August provided the answer. Read more.

Read more

Newsletter – August 2022 – Opportunities Fund

Tuesday, 20th September, 2022

The Merchant Opportunities Fund (MOF or Fund) pulled back slightly along with the market during the month of August to be up 18.40% for the Financial Year. Read more.

Read more

Newsletter – July 2022 – Biotech Fund

Monday, 8th August, 2022

At the closing bell on the last trading day of the Financial Year, the ASX Biotech Sector was down approximately 40% for the full Financial Year. Read more.

Read more

Newsletter – July 2022 – Opportunities Fund

Thursday, 4th August, 2022

Well, that was a financial year to forget! Read more.

Read more

Newsletter – May 2022 – Opportunities Fund

Thursday, 16th June, 2022

The MOF is currently down 15.41% since 30 June against a Small Ordinaries Index that is at the time of writing, down 19.94% for the Financial Year. Read more.

Read more

Newsletter – May 2022 – Biotech Fund

Thursday, 16th June, 2022

Against the ASX & US Listed Biotech Indexes we are faring better but at the moment it’s all a little painful. Read more.

Read more

Newsletter – April 2022 – Biotech Fund

Monday, 23rd May, 2022

April brought another volatile month on the stock market. The release of inflation numbers and a rise in interest rates both globally and domestically led to a shakeout. Read more.

Read more

Newsletter – April 2022 – Opportunities Fund

Wednesday, 18th May, 2022

With the Small Ordinaries off 15.36% for the 6 months, the Merchant Opportunities Fund (MOF) over for the financial year is currently down 12.18%. Read more.

Read more

Newsletter – March 2022 – Biotech Fund

Thursday, 21st April, 2022

As the dust settles on the month of March 2022 for the Merchant Biotech Fund increasing inflation and the Russian war in Ukraine continue to plague the technology/healthcare sector. Read more.

Read more

OzHarvest – Help Keep The Wheels Turning + Provide Vital Food Relief

Wednesday, 20th April, 2022

I’m helping OzHarvest raise money to feed people in need and I’d love your support. Read more.

Read more

Newsletter – March 2022 – Opportunities Fund

Tuesday, 19th April, 2022

The Merchant Opportunities Fund is currently down 6.25% for the Financial Year having regained some ground to March 31st. Read more.

Read more

Brook Corte Money News Interview with Andrew Chapman

Tuesday, 5th April, 2022

Biotech companies are at the centre of future success, with one investment group setting its sights on the industry. These are the companies working to help us live longer, healthier lives by creating cutting edge treatments for devastating diseases. Merchant Funds’ new Biotech fund focuses on emerging Australian biotech, medical and health sciences companies, giving […]

Read more

Newsletter – February 2022 – Biotech Fund

Wednesday, 16th March, 2022

The Merchant Biotech Fund continued to suffer during February with the Biotechnology and Technology sectors both being hardest hit as a result of the Russian invasion of Ukraine.

Read more

Newsletter – February 2022 – Opportunities Fund

Tuesday, 15th March, 2022

The Merchant Opportunities Fund continued its retracement at the hands of the market gods in February.

Read more

Newsletter – January 2022 – Biotech Fund

Monday, 21st February, 2022

Auspiciously January 2022 will go down as the first month investing for the Merchant Biotech Fund.

Read more

Newsletter – January 2022 – Opportunities Fund

Wednesday, 16th February, 2022

January was a tough month for equity markets. The long-awaited inflation figures officially came into focus.

Read more

Get in Touch

  • This field is for validation purposes and should be left unchanged.